Literature DB >> 22872517

Predicting the factors of lateral lymph node metastasis in papillary microcarcinoma of the thyroid in eastern China.

Rui-chao Zeng1, Quan Li, Kuai-lu Lin, Wei Zhang, Er-li Gao, Guan-li Huang, Xiao-hua Zhang, Min-hua Zheng.   

Abstract

INTRODUCTION: Lateral lymph node metastasis is common in papillary thyroid microcarcinoma (PTMC). The present study evaluated the clinicopathologic characteristics and ultrasonographic (US) findings in predicting lateral LNM from PTMC in eastern China.
MATERIALS AND METHODS: A total of 176 patients with confirmed PTMC by final histological examination who underwent central lymph node dissection (LND) and lateral LND were enrolled in our study. The clinicopathological and US data from the cases were analyzed retrospectively to determine the independent predictive factors for lateral LNM. Then, a scoring system was developed on the basis of independent factors. The sum of the points for individuals was evaluated for the value in predicting lateral LNM.
RESULTS: Central LNM, underlying Hashimoto's thyroiditis, upper pole location, no well-defined margin and presence of calcifications were independent predictive factors for lateral LNM on multivariate analysis. Clinicopathological and US index points were statistically significant, with ≤ 2 favoring lateral LNM negativity with a sensitivity of 83.3 %, positive predictive value of 89.6 % and negative predictive value of 72.9 %.
CONCLUSIONS: When the evaluation for lateral lymph nodes from a preoperative approach is inadequate or not obvious, our scoring system for prediction of lateral LNM can be another choice. Patients with clinicopathological and US index points ≤ 2 could be considered as lateral LNM negative, so more diagnostic approach is recommended for patients with clinicopathological and US index points >2.

Entities:  

Mesh:

Year:  2012        PMID: 22872517     DOI: 10.1007/s12094-012-0875-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  31 in total

1.  Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-11       Impact factor: 3.352

2.  Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis.

Authors:  Sang Soo Kim; Byung Joo Lee; Jin Choon Lee; Seong-Jang Kim; Yun Kyung Jeon; Mi Ra Kim; Jeong Eun Huh; Ji Young Mok; Bo Hyun Kim; Yong Ki Kim; In Joo Kim
Journal:  Head Neck       Date:  2010-11-29       Impact factor: 3.147

3.  The WHO histological classification of thyroid tumors: a commentary on the second edition.

Authors:  C Hedinger; E D Williams; L H Sobin
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

4.  Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma.

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

5.  Routine central compartment lymph node dissection for patients with papillary thyroid carcinoma.

Authors:  David I Kutler; Audrey D Crummey; William I Kuhel
Journal:  Head Neck       Date:  2011-03-17       Impact factor: 3.147

6.  Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

Authors:  F D Gilliland; W C Hunt; D M Morris; C R Key
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

7.  Papillary microcarcinoma of the thyroid: how should it be treated?

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

8.  Ill-defined edge on ultrasonographic examination can be a marker of aggressive characteristic of papillary thyroid microcarcinoma.

Authors:  Yasuhiro Ito; Kaoru Kobayashi; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2005-08       Impact factor: 3.352

9.  Pattern of lateral neck metastases in N0 papillary thyroid carcinoma.

Authors:  Vincent Patron; Cécile Bedfert; Guy Le Clech; Karine Aubry; Franck Jegoux
Journal:  BMC Cancer       Date:  2011-01-11       Impact factor: 4.430

10.  Prognostic parameters for recurrence of papillary thyroid microcarcinoma.

Authors:  Tae Yong Kim; Suck Joon Hong; Jung Min Kim; Won Gu Kim; Gyungyub Gong; Jin Sook Ryu; Won Bae Kim; Sung-Cheol Yun; Young Kee Shong
Journal:  BMC Cancer       Date:  2008-10-14       Impact factor: 4.430

View more
  11 in total

1.  Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.

Authors:  Yingying Xiang; Kuailu Lin; Siyang Dong; L I Qiao; Qiuxiang He; Xiaohua Zhang
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

Review 2.  The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis.

Authors:  Liang-Sen Liu; Jia Liang; Jun-Hong Li; Xue Liu; Li Jiang; Jian-Xiong Long; Yue-Ming Jiang; Zhi-Xiao Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-09-19       Impact factor: 2.503

3.  Predicting the factors associated with central lymph node metastasis in clinical node-negative (cN0) papillary thyroid microcarcinoma.

Authors:  Cui Zhang; Bao-Jun Li; Zhao Liu; Ling-Ling Wang; Wen Cheng
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-13       Impact factor: 2.503

4.  Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.

Authors:  Jia-Wei Feng; An-Cheng Qin; Jing Ye; Hua Pan; Yong Jiang; Zhen Qu
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

5.  E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma.

Authors:  Masanori Nakamura; Naoyoshi Onoda; Satoru Noda; Shinichiro Kashiwagi; Naoki Aomatsu; Kento Kurata; Hidemi Kawajiri; Tsutomu Takashima; Tetsuro Ishikawa; Kosei Hirakawa
Journal:  Mol Clin Oncol       Date:  2013-12-05

6.  Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma.

Authors:  Soo-Yeon Kim; Eunjung Lee; Se Jin Nam; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Kyung Hwa Han; Jin Young Kwak
Journal:  PLoS One       Date:  2017-04-18       Impact factor: 3.240

7.  Preoperative predictors of lateral neck lymph node metastasis in papillary thyroid microcarcinoma.

Authors:  Zheng Liu; Jianyong Lei; Yang Liu; Yuxia Fan; Xiaoming Wang; Xiubo Lu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

8.  Is thyroid nodule location associated with malignancy risk?

Authors:  Valeria Ramundo; Livia Lamartina; Rosa Falcone; Laura Ciotti; Cristiano Lomonaco; Marco Biffoni; Laura Giacomelli; Marianna Maranghi; Cosimo Durante; Giorgio Grani
Journal:  Ultrasonography       Date:  2018-11-06

9.  Predicting factors of lateral neck lymph node metastases in patients with papillary thyroid microcarcinoma.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng; Xiaodong He
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

10.  Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.

Authors:  Yanping Gong; Jing Yang; Shuping Yan; Anping Su; Feng Liu; Rixiang Gong; Jingqiang Zhu; Zhihui Li
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.